Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'2-UTR landscape across seven tumour types

Nature Communications

Volumn 5, Issue , 2014, Pages

  Xia, Zheng ^a   Donehower, Lawrence A ^a   Cooper, Thomas A ^a   Neilson, Joel R ^a   Wheeler, David A ^a   Wagner, Eric J ^b   Li, Wei ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINASE; MICRORNA; RNA; 3' UNTRANSLATED REGION; CSTF2T PROTEIN, HUMAN; MESSENGER RNA; RNA BINDING PROTEIN;

BIOMARKER; CANCER; ENZYME ACTIVITY; LANDSCAPE; TUMOR;

3' UNTRANSLATED REGION; ALTERNATIVE POLYADENYLATION; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CONTROLLED STUDY; GENE IDENTIFICATION; GENE REPRESSION; HUMAN; HUMAN CELL; POLYADENYLATION; RNA SEQUENCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; SEQUENCE ANALYSIS;

3' UNTRANSLATED REGIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; POLYADENYLATION; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, RNA;

EID: 84923366707     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6274     Document Type: Article

References (55)

1. Elkon, R., Ugalde, A. P. & Agami, R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 14, 496-506 (2013).
2. Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 30 untranslated regions and fewer microRNA target sites. Science 320, 1643-1647 (2008).
3. Derti, A. et al. A quantitative atlas of polyadenylation in five mammals. Genome Res. 22, 1173-1183 (2012).
4. Tian, B., Hu, J., Zhang, H. & Lutz, C. S. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 33, 201-212 (2005).
5. Barreau, C., Paillard, L. & Osborne, H. B. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138-7150 (2005).
6. Jacobsen, A. et al. Analysis of microRNA-target interactions across diverse cancer types. Nat. Struct. Mol. Biol. 20, 1325-1332 (2013).
7. Takagaki, Y. & Manley, J. L. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol. Cell 2, 761-771 (1998).
8. Mayr, C. & Bartel, D. P. Widespread shortening of 30 UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684 (2009).
9. Elkon, R. et al. E2F mediates enhanced alternative polyadenylation in proliferation. Genome. Biol. 13, R59 (2012).
10. Singh, P. et al. Global changes in processing of mRNA 30 untranslated regions characterize clinically distinct cancer subtypes. Cancer Res. 69, 9422-9430 (2009).
11. Morris, A. R. et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer Res. 18, 5256-5266 (2012).
12. Ji, Z., Lee, J. Y., Pan, Z., Jiang, B. & Tian, B. Progressive lengthening of 30 untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl Acad. Sci. USA 106, 7028-7033 (2009).
13. Hoque, M. et al. Analysis of alternative cleavage and polyadenylation by 30 region extraction and deep sequencing. Nat. Methods 10, 133-139 (2013).
14. Sun, Y., Fu, Y., Li, Y. & Xu, A. Genome-wide alternative polyadenylation in animals: insights from high-throughput technologies. J. Mol. Cell Biol. 4, 352-361 (2012).
15. Pickrell, J. K. et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768-772 (2010).
16. Katz, Y., Wang, E. T., Airoldi, E. M. & Burge, C. B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 7, 1009-1015 (2010).
17. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
18. Griebel, T. et al. Modelling and simulating generic RNA-Seq experiments with the flux simulator. Nucleic Acids Res. 40, 10073-10083 (2012).
19. Bullard, J. H., Purdom, E., Hansen, K. D. & Dudoit, S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics 11, 94 (2010).
20. Consortium, M. et al. The MicroArray Quality Control (MAQC) project shows inter-and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151-1161 (2006).
21. Miura, P., Shenker, S., Andreu-Agullo, C., Westholm, J. O. & Lai, E. C. Widespread and extensive lengthening of 30 UTRs in the mammalian brain. Genome Res. 23, 812-825 (2013).
22. Ulitsky, I. et al. Extensive alternative polyadenylation during zebrafish development. Genome Res. 22, 2054-2066 (2012).
23. Zhang, H., Hu, J., Recce, M. & Tian, B. PolyA-DB: a database for mammalian mRNA polyadenylation. Nucleic Acids Res. 33, D116-D120 (2005).
24. Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009).
25. Beaudoing, E., Freier, S., Wyatt, J. R., Claverie, J. M. & Gautheret, D. Patterns of variant polyadenylation signal usage in human genes. Genome Res. 10, 1001-1010 (2000).
26. Bailey, T. L. DREME: motif discovery in transcription factor ChIP-seq data. Bioinformatics 27, 1653-1659 (2011).
27. Shepard, P. J. et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA 17, 761-772 (2011).
28. Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 (2014).
29. Andersen, P. K. & Gill, R. D. Cox's regression model for counting processes: a large sample study. Ann. Statist. 1100-1120 (1982).
30. Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134, 703-707 (2008).
31. Cassago, A. et al. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc. Natl Acad. Sci. USA 109, 1092-1097 (2012).
32. Aledo, J. C., Gomez-Fabre, P. M., Olalla, L. & Marquez, J. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm. Genome 11, 1107-1110 (2000).
33. de la Rosa, V. et al. A novel glutaminase isoform in mammalian tissues. Neurochem. Int. 55, 76-84 (2009).
34. Elgadi, K. M., Meguid, R. A., Qian, M., Souba, W. W. & Abcouwer, S. F. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol. Genomics 1, 51-62 (1999).
35. Gao, P. et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765 (2009).
36. van den Heuvel, A. P., Jing, J., Wooster, R. F. & Bachman, K. E. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol. Ther. 13, 1185-1194 (2012).
37. Stacey, S. N. et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat. Genet. 43, 1098-1103 (2011).
38. Wiestner, A. et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 109, 4599-4606 (2007).
39. Di Giammartino, D. C., Nishida, K. & Manley, J. L. Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43, 853-866 (2011).
40. Shi, Y. Alternative polyadenylation: new insights from global analyses. RNA 18, 2105-2117 (2012).
41. Shi, Y. et al. Molecular architecture of the human pre-mRNA 30 processing complex. Mol. Cell 33, 365-376 (2009).
42. Martin, G., Gruber, A. R., Keller, W. & Zavolan, M. Genome-wide analysis of pre-mRNA 30 end processing reveals a decisive role of human cleavage factor I in the regulation of 30 UTR length. Cell Rep. 1, 753-763 (2012).
43. Yao, C. et al. Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc. Natl Acad. Sci. USA 109, 18773-18778 (2012).
44. Wang, W., Wei, Z. & Li, H. A change-point model for identifying 30 UTR switching by next-generation RNA sequencing. Bioinformatics 30, 2162-2170 (2014).
45. Lin, Y. et al. An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 40, 8460-8471 (2012).
46. Hofree, M., Shen, J. P., Carter, H., Gross, A. & Ideker, T. Network-based stratification of tumor mutations. Nat. Methods 10, 1108-1115 (2013).
47. Masamha, C. P. et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 509, 412-416 (2014).
48. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546-1558 (2013).
49. Bohnert, R. & Ratsch, G. rQuant.web: a tool for RNA-Seq-based transcript quantitation. Nucleic Acids Res. 38, W348-W351 (2010).
50. Li, J., Jiang, H. & Wong, W. H. Modeling non-uniformity in short-read rates in RNA-Seq data. Genome Biol. 11, R50 (2010).
51. Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1-22 (2010).
52. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (2007).
53. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
54. John, B. et al. Human MicroRNA targets. PLoS Biol. 2, e363 (2004).
55. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).